Short answer
Crinetics Pharmaceuticals, Inc. (CRNX) filed an 8-K current report with the SEC on June 22, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 102,030,415 shares represented, approximately 97% of eligible voting shares, indicating strong shareholder participation.
Crinetics Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 102,030,415 shares represented, approximately 97% of eligible voting shares, indicating strong shareholder participation
- Three Class II directors elected through 2029; Weston Nichols received 90,208,564 votes for
- PwC ratified as independent auditor for fiscal year ending December 31, 2026, with 101,675,974 votes for
- Executive compensation approved on advisory basis, with 91,657,992 votes for and 2,698,538 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Crinetics Pharmaceuticals, Inc. 8-K filings
Get the next CRNX 8-K as it lands
Follow CRNX for push alerts, or ask the research agent what this filing means.